Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets in Clinical Practice
Peter Rieckmann, View ORCID ProfileDiego Centonze, Gavin Giovannoni, Le H. Hua, View ORCID ProfileCelia Oreja-Guevara, Daniel Selchen, View ORCID ProfilePer Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, View ORCID ProfileBassem Yamout
doi: https://doi.org/10.1101/2021.06.22.21259308
Peter Rieckmann
1Center for Clinical Neuroplasticity, Medical Park Loipl, Bischofswiesen, Department of Neurology, University of Erlangen, Germany
Diego Centonze
2Unit of Neurology and Neurorehabilitation, IRCCS Neuromed, Pozzilli (IS), Italy
Gavin Giovannoni
3Queen Mary University of London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, UK
Le H. Hua
4Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA
Celia Oreja-Guevara
5Neurology, Hospital Clínico San Carlos, Idissc, Madrid, Spain
6Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Spain
Daniel Selchen
7University of Toronto, Division of Neurology, St. Michael’s Hospital, Toronto, ON, Canada
Per Soelberg Sørensen
8Danish Multiple Sclerosis Center, Department of Neurology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark
Patrick Vermersch
9Université de Lille, INSERM-U1172, Centre Hospitalier Universitaire de Lille, Fédératif Hospitalo-Universitaire Precise, Lille, France
Heinz Wiendl
10Department of Neurology, Institute of Translational Neurology, University of Münster, Münster, Germany
Hashem Salloukh
11Ares Trading SA, Eysins, Switzerland (an affiliate of Merck KGaA)
Bassem Yamout
12Nehme and Therese Tohme Multiple Sclerosis Center, American University of Beirut, Beirut, Lebanon
13Neurology Institute, Harley Street Medical Center, Abu Dhabi, UAE
Article usage
Posted September 10, 2021.
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets in Clinical Practice
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout
medRxiv 2021.06.22.21259308; doi: https://doi.org/10.1101/2021.06.22.21259308
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets in Clinical Practice
Peter Rieckmann, Diego Centonze, Gavin Giovannoni, Le H. Hua, Celia Oreja-Guevara, Daniel Selchen, Per Soelberg Sørensen, Patrick Vermersch, Heinz Wiendl, Hashem Salloukh, Bassem Yamout
medRxiv 2021.06.22.21259308; doi: https://doi.org/10.1101/2021.06.22.21259308
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (628)
- Anesthesia (165)
- Cardiovascular Medicine (2377)
- Dermatology (207)
- Emergency Medicine (379)
- Epidemiology (11775)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3744)
- Geriatric Medicine (350)
- Health Economics (634)
- Health Informatics (2399)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (105)
- Nephrology (398)
- Neurology (3507)
- Nursing (198)
- Nutrition (526)
- Oncology (1824)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (233)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1035)
- Primary Care Research (420)
- Public and Global Health (6145)
- Radiology and Imaging (1280)
- Respiratory Medicine (828)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)